Close
Smartlab Europe
Achema middle east

Press Releases

Saint-Gobain Performance Plastics acquires Applied Bioprocess Containers

Saint-Gobain Performance Plastics has completed the acquisition of Applied Bioprocess Containers a U.S.-based supplier of single use containers and fluid transfer systems for the biopharmaceutical industry. Based in Plymouth Minnesota Applied Bioprocess Containers specializes...

Square 1 Bank Announces $2.25M Debt Facility to Carolus Therapeutics

Square 1 Bank the premier banking partner to entrepreneurs and the venture capital community today announced it has provided a $2.25M debt facility to new client Carolus Therapeutics a biopharmaceutical company. The financing will support future growth. ...

Dotmatics teams with leading distributor to launch powerful life science informatics platform

Dotmatics leading supplier of enterprise life science informatics solutions announces the appointment of Shanghai Budou Technology as their Chinese distributor. The partnership will make Dotmatics’ versatile informatics platform available to a large new market...

KSI & RFIDeas Introduce an Integrated Solution for ePrescribe

RFIDeas the innovator of WaveID® and KSI Inc. will introduce the first compliant ePrescribe keyboard for controlled substances at this year's HIMSS Annual Conference & Exhibition held in New Orleans March 3-7 2013. RFIDeas...

Novozymes Biopharma’s rAlbumin approved in Japan as MAQUET expands into new market

Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, has announced that one of its leading customers has achieved approval of a medical device in Japan using Recombumin® Alpha - formerly Albucult®, a recombinant human albumin...

Promethera Biosciences opens the French part of its clinical trial in cell therapy

Promethera Biosciences, a Belgian biotechnology company developing Promethera(R) HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announces today that it has successfully treated a patient with liver progenitor...

Trophos announces positive interim review in pivotal study of olesoxime in Spinal Muscular Atrophy

Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for under-served medical needs in neurology and cardiology, announces today the completion of the interim analysis of the pivotal efficacy study of olesoxime...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »